NIH, Moderna’s COVID-19 vaccine headed to Phase III trial
Editor's Note Researchers testing a COVID-19 vaccine being developed by Dr Anthony Fauci’s team at the National Institutes of Health (NIH) and Moderna Inc, reported July 14 that the vaccine was able to produce neutralizing antibodies in the 45 trial participants inoculated in March. Moderna is scheduled to launch a late-stage…
Pfizer could have COVID-19 vaccine by October
Editor's Note Food & Drug Administration (FDA) approval of Pfizer’s COVID-19 vaccine could happen in October, the July 12 Time reports. The company was granted FDA Fast Track designation for the vaccine. Pfizer’s vaccine, being developed with its German biotech partner BioNTech, uses a messenger-RNA, genetics-based approach. Pfizer CEO Albert…
Late-stage COVID-19 vaccine trials to start this summer
Editor's Note The National Institute of Allergy and Infectious Diseases director Anthony Fauci says COVID-19 vaccine candidates will start moving into late-stage clinical trials by the end of July, continuing through the summer and into fall, the July 2 Reuters reports. The director of the National Institutes of Health, Dr…
Mayo Clinic launches neutralizing antibody test for COVID-19
Editor's Note The Mayo Clinic on June 11 announced that it had launched a new SARS-CoV-2 neutralizing antibody test that will be available to select labs, blood banks, and biopharma clients in late June. The test measures the level of neutralizing antibodies against SARS-CoV-2, the virus that causes COVID-19. Neutralizing…
FDA encourages recovered COVID-19 patients to donate plasma for development of therapies
Editor's Note The Food & Drug Administration (FDA) on April 16 provided an update on a potential treatment for COVID-19, called convalescent plasma, and encouraged those who have recovered from the coronavirus to donate this antibody-rich plasma to help others fight this disease. Patients who have fully recovered for at…
FDA issues COVID-19 update
Editor's Note The Food & Drug Administration (FDA) on April 7 issued an update on actions the agency has taken in its ongoing response to the COVID-19 pandemic. The actions include: a guidance for remote ophthalmic assessment and monitoring devices to facilitate patient care while reducing patient and healthcare provider…
Flu advice is stressing vaccinations
The government and health care system are gearing up for an outbreak this fall of the H1N1 virus in addition to seasonal flu. Officials offered advice in an August 20, 2009 call hosted by the Department of Health and Human Services. Health care workers are among 5 initial target groups…
Free Daily News
- Share your expertise! Topics, speakers sought for 2025 ORBMC
- FDA approves imaging drug for detecting cancer after lumpectomy
- Penn Medicine anesthesia, waste initiatives boost OR sustainability
- Survey assesses continued impact of Change Healthcare cyberattack
- WHO sounds alarm on potential spread of bird flu
- Allison Massari to deliver hopeful, empowering keynote address at OR Manager Conference 2024
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
- Drug shortages higher than ever
- FDA announces class 1 recalls for premixed embolic, infusion pump software
- Academic medical centers identify performance-improvement priorities